Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2008
Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal studyB Brochet, M S A Deloire, M Bonnet, et al.Revue Neurologique|July 29, 2020
Should we prevent thrombosis related to intravenous immunoglobulin infusions with systematic anticoagulant prophylaxis?R Arcani, A-M Grapperon, G Venton, et al.Revue Neurologique|November 9, 2023
Epidemiology of myasthenia gravis in France: A retrospective claims database study (STAMINA)E Salort-Campana, P Laforet, G de Pouvourville, et al.Revue Neurologique|June 3, 2026
Current management and treatment of patients with myasthenia gravis in France: A survey of the neurologist's perspectiveP Cintas, E Salort-Campana, S Demeret, et al.Neuromuscular Disorders : NMD|October 27, 2009
Immunolabelling and flow cytometry as new tools to explore dysferlinopathiesN Wein, M Krahn, S Courrier, et al.Revue Neurologique|May 2, 2020
Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases NetworkG Solé, E Salort-Campana, Y Pereon, et al.European Journal of Neurology|June 25, 2026
Quantitative Neuromuscular MRI in CIDP Patients: Interest of a Multiparametric ApproachA Guérémy, E Fortanier, C P Michel, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 19, 2005
Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosisM S A Deloire, E Salort, M Bonnet, et al.Revue Neurologique|September 7, 2013
The French Pompe registry. Baseline characteristics of a cohort of 126 patients with adult Pompe diseaseP Laforêt, K Laloui, B Granger, et al.Revue Neurologique|September 7, 2015
Myofibrillar myopathies: State of the art, present and future challengesA Béhin, E Salort-Campana, K Wahbi, et al.Pageof 3